| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/21/2011 | US20110092458 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases |
| 04/21/2011 | US20110092447 Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions |
| 04/21/2011 | US20110092420 Selenium containing modifying agents and conjugates |
| 04/21/2011 | US20110092417 Leptin fusion proteins |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091576 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells |
| 04/21/2011 | US20110091543 Oral delivery of modified transferrin fusion proteins |
| 04/21/2011 | US20110091534 Compositions comprising polymeric micelles for drug delivery |
| 04/21/2011 | US20110091525 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091506 Vaccine compositions |
| 04/21/2011 | US20110091505 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/21/2011 | US20110091501 Recombinant Rhinovirus Vectors |
| 04/21/2011 | US20110091498 Methods of stimulating an immune response against prostate specific antigen |
| 04/21/2011 | US20110091497 Method For Identifying and Validating Dominant T Helper Cell Epitopes Using An HLA-DM-Assisted Class II Binding Assay |
| 04/21/2011 | US20110091496 Methods and compositions for the delivery of vaccines to disrupted epithelium |
| 04/21/2011 | US20110091492 Escherichia coli immunogens with improved solubility |
| 04/21/2011 | US20110091489 Survivin peptide vaccine |
| 04/21/2011 | US20110091484 Compositions and methods for preventing or treating a viral infection |
| 04/21/2011 | US20110091478 Methods of using antibodies against human il-22 |
| 04/21/2011 | US20110091477 Modulators of hepatocyte growth factor activator |
| 04/21/2011 | US20110091475 Anti-Human Interleukin-20 Antibodies |
| 04/21/2011 | US20110091473 Novel antibody therapies |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091457 Method for prognosticating the clinical response of a patient to b-lymphocyte inhibiting or depleting therapy |
| 04/21/2011 | US20110091453 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory diseases |
| 04/21/2011 | US20110091450 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | US20110091448 Methods for regulation of stem cells |
| 04/21/2011 | US20110091445 Modulation of intestinal flora of hiv patients |
| 04/21/2011 | US20110091441 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
| 04/21/2011 | US20110091434 Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucosyltransferase |
| 04/21/2011 | US20110091415 Hydroxyethyl Starch-Containing Polypeptide Compositions |
| 04/21/2011 | US20110091413 Therapeutic use of interleukin-2 mutants |
| 04/21/2011 | US20110091411 Interleukin-1 Muteins Linked to Virus-Like Particles to Treat IL-1 Associated Diseases |
| 04/21/2011 | US20110091410 Engineered CXCL12 Alpha Locked Dimer Polypeptide |
| 04/21/2011 | US20110091407 Polymer derived from linear polyethylenimine for gene transfer |
| 04/21/2011 | US20110091385 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 04/21/2011 | US20110091378 Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | DE202009017772U1 Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid Combination products with cytokine antagonist and corticosteroid |
| 04/21/2011 | DE102009049679A1 Pyrazolopyrimidinderivate Pyrazolopyrimidinderivate |
| 04/21/2011 | CA2777563A1 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/21/2011 | CA2776028A1 Pyrrolo[2,3-d]pyrimidine compounds |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | CA2735343A1 Compositions that include anthocyanidins and methods of use |
| 04/20/2011 | EP2312315A1 Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component |
| 04/20/2011 | EP2311945A1 Bispecific antibodies substituting for functional proteins |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311870A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311869A1 Use of mammalian cytokine; related reagents |
| 04/20/2011 | EP2311868A1 Compositions and methods for the treatment of immune related diseases |
| 04/20/2011 | EP2311818A1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug |
| 04/20/2011 | EP2311807A1 Compounds and composition as protein kinase inhibitors |
| 04/20/2011 | EP2311529A1 Botanical extract composition |
| 04/20/2011 | EP2311493A1 Cytotoxic composition |
| 04/20/2011 | EP2311491A1 Composition comprising an antibody against macrophage colony-stimulating factor (M-CSF) and a chelating agent |
| 04/20/2011 | EP2311484A1 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 04/20/2011 | EP2311465A1 Remedies for diseases to be applied to eye |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2310405A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 04/20/2011 | EP2310366A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/20/2011 | EP2310040A1 Method to stimulate immune function and regeneration |
| 04/20/2011 | EP2061444B1 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 04/20/2011 | EP1946752B1 Anti-allergic agent |
| 04/20/2011 | EP1784200B1 Method and composition for modulation of systemic inflammatory responses syndrome (sirs) |
| 04/20/2011 | EP1624892B1 Therapeutic use of anti-cs1 antibodies |
| 04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
| 04/20/2011 | CN1981845B Chinese-medicinal composition, its production and use |
| 04/20/2011 | CN102027018A Agent for treating disease |
| 04/20/2011 | CN102027017A Agent for treating disease |
| 04/20/2011 | CN102027016A Agent for treating disease |
| 04/20/2011 | CN102026647A Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 04/20/2011 | CN102026616A Substances that increase the activation threshold of immune cells |
| 04/20/2011 | CN102021162A High-activity bifidobacterium powder and preparation method thereof |
| 04/20/2011 | CN102020711A Casing smooth muscle collagen preparation method and functional study |
| 04/20/2011 | CN102020643A dihydropteridine ketone derivative, and preparation method and medicinal application thereof |
| 04/20/2011 | CN102020640A Tetrahydroindolone and tetrahydroindolone derivative as well as preparation method and medical application thereof |
| 04/20/2011 | CN102020638A 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102020623A Butterbur extract as well as preparation method and application thereof |
| 04/20/2011 | CN102020607A 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 04/20/2011 | CN102020588A Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102018982A Humidifier health-care tablet and preparation method thereof |
| 04/20/2011 | CN102018963A MiR-125a for adjusting regulated on activation normal T cell expressed and secreted (RANTES) expressions as well as composition and application thereof |
| 04/20/2011 | CN102018954A Capsule capable of resisting toxicity of radiotherapy and chemotherapy and manufacture process thereof |
| 04/20/2011 | CN102018897A Traditional Chinese medicine health protection tea with efficacy of nourishing yin and cooling blood |
| 04/20/2011 | CN102018885A Chinese medicinal preparation for increasing immunity of organism |
| 04/20/2011 | CN102018877A Traditional Chinese medicine for promoting psychological and physiological wounds to heal |
| 04/20/2011 | CN102018839A Medicinal wine for dissolving thrombus and prolonging life |
| 04/20/2011 | CN102018835A Method for separating effective components in traditional Chinese medicine curculigo orchioides by membrane separation method |
| 04/20/2011 | CN102018816A Traditional Chinese medicine for treating anaphylactoid purpura |
| 04/20/2011 | CN102018811A Chinese materia medica preparation for treating urticaria |
| 04/20/2011 | CN102018797A Traditional Chinese medicine composition with allergy soothing effect, preparation and preparation method thereof |
| 04/20/2011 | CN102018791A Drug for treating allergic purpura |
| 04/20/2011 | CN102018726A Method for preparing animal hoof nail extract |
| 04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 04/20/2011 | CN102018712A Pharmaceutical composition comprising dextromethorphan, chlorpheniramine and pseudoephedrine and preparation method thereof |
| 04/20/2011 | CN102018709A Tablet capsules with Loratadine tablets and Ambroxol hydrochloride tablets |
| 04/20/2011 | CN102018680A Emedastine difumarate sustained release tablets and preparation method thereof |